Since doxorubicin promotes PKR-mediated cell death in mouse embryonic fibroblasts [26] and regulates PKR–eIF2α signaling in breast cancer cells [3], we tested the effects of PKR on doxorubicin-treated HCC1143 cells. The gene discussed is EIF2A; the disease is breast cancer.